Urinary Bladder Cancer, Muscle-invasive
1 competing product in clinical development for Urinary Bladder Cancer, Muscle-invasive.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Pembrolizumab + Enfortumab Vedotin | Astellas Pharma | Phase 3 | Active | 44 |